Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1

Ying Wang1, David M Lonard1, Yang Yu1

  • 1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.

Cancer Research
|January 7, 2014
PubMed

Insights

Bufalin, a cardiac glycoside, effectively inhibits SRC-3 and SRC-1 coactivators, crucial in cancer progression. This small molecule shows promise as a broad-spectrum cancer therapeutic, reducing tumor growth in preclinical models.

Area of Science:

  • Molecular Biology
  • Oncology
  • Pharmacology

Background:

  • Transcription factors rely on coactivators to regulate gene expression.
  • The p160 steroid receptor coactivator (SRC) family (SRC-1, SRC-2, SRC-3) plays a significant role in cancer cell proliferation, invasion, and metastasis.
  • SRC family members are potential therapeutic targets for novel chemotherapeutics.

Purpose of the Study:

  • To identify small-molecule inhibitors targeting the SRC coactivator family.
  • To evaluate the efficacy of identified inhibitors in preclinical cancer models.

Main Methods:

  • High-throughput screening of small molecules.
  • Assays to determine SRC-3 and SRC-1 inhibition.
  • In vitro cancer cell growth inhibition assays.
  • In vivo mouse xenograft models of breast cancer using nanoparticle delivery systems.

Main Results:

  • Bufalin was identified as a potent inhibitor of SRC-3 and SRC-1.
  • Bufalin induced SRC-3 protein degradation.
  • Bufalin demonstrated potent cancer cell growth inhibition at nanomolar concentrations.
  • Nanoparticle-formulated bufalin reduced tumor growth in a mouse xenograft model.

Conclusions:

  • Bufalin is a potent small-molecule inhibitor of SRC-3 and SRC-1.
  • Bufalin exhibits anti-cancer activity both in vitro and in vivo.
  • Bufalin represents a promising candidate for a broad-spectrum cancer therapeutic.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
6.6K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.0K
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
106
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.2K
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
119
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
2.2K